Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial
Dana-Farber Cancer Institute
Sara M Tolaney; Nabihah Tayob; Chau Dang; Denise A Yardley; Steven J Isakoff; Vicente Valero; Meredith Faggen; Therese Mulvey; Ron Bose; Jiani Hu; Douglas Weckstein; Antonio C Wolff; Katherine Reeder-Hayes; Hope S Rugo; Bhuvaneswari Ramaswamy; Dan Zuckerman; Lowell Hart; Vijayakrishna K Gadi; Michael Constantine; Kit Cheng; Frederick Briccetti; Bryan Schneider; Audrey Merrill Garrett; Kelly Marcom; Kathy Albain; Patricia DeFusco; Nadine Tung; Blair Ardman; Rita Nanda; Rachel C Jankowitz; Mothaffar Rimawi; Vandana Abramson; Paula R Pohlmann; Catherine Van Poznak; Andres Forero-Torres; Minetta Liu; Kathryn Ruddy; Yue Zheng; Shoshana M Rosenberg; Richard D Gelber; Lorenzo Trippa; William Barry; Michelle DeMeo; Harold Burstein; Ann Partridge; Eric P Winer; Ian Krop